Prosthetic Heart Valve Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Market is Segmented by Type of Valve (Mechanical Heart Valve, Bioprosthetic Heart Valve, Transcatheter, and Heart Valve), Position, and Geography

Market Snapshot

 Prosthetic heart valve market Overview
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 10.5 %
 Prosthetic heart valve market Key Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The prosthetic heart valve market will show rapid growth due to the subsequent growth in the prevalence of heart valve disease and rising regulatory approvals for a new and advanced prosthetic heart valve.

Valvular heart disease (VHD) places a significant burden on the global healthcare system. According to the American College of Cardiology, there are approximately 5 million Americans that are being diagnosed with HVD every year. VHD mainly affects the older population as a result of calcium buildup and scarring in the valve cusp due to ageing. The prevalence of VHD in the population aged 18-44 and 75 years was 0.7% and 13.0%, respectively in 2012. Therefore the rapid growth in the ageing population and the consequent rise in the prevalence of VHD is expected to drive the market growth for the prosthetic heart valve market.

The prosthetic valves market has also witnessed several clinical trials in recent years especially in the European countries due to uniform regulations and high prevalence of heart diseases.

Scope of the Report

The prosthetic heart valve is a device implanted in a patient suffering from valvular heart disease, which results in malfunction of one or more valves present in the human heart. The treatment for such disease includes the replacement of a natural heart valve with a prosthetic heart valve and thus decreases the mortality and morbidity related to cardiac valve disorders.

By Type of Valve
Mechanical Heart Valve
Bioprosthetic Heart Valve
Transcatheter Heart Valve
By Position
Mitral Valve
Aortic Valve
Other Positions
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East & Africa
GCC
South Africa
Rest of Middle East & Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Transcatheter Heart Valve Segment is Expected to Register Robust Growth During the Forecast Period

The transcatheter heart valve segment is expected to hold a significant share in the global market and the large share can be attributed to the various factors such as ease of implantation, rise in the number of transcatheter heart valve surgery centres and growing of the patient population. There are also growth opportunities in emerging countries and the use of transcatheter heart valves for new indications (treatment of intermediate-risk patients and high-risk patients) are thus expected to provide numerous opportunities for the market growth during the forecast period.

In addition, the rise in adoption rate for transcatheter heart valve implantation procedure and new device approvals are expected to lead the growth of transcatheter heart valve market.

 Prosthetic heart valve market Key Trends

North America is Found to be the Largest Market for the Prosthetic Heart Valve

North America is expected to dominate the prosthetic heart valve market, followed by Europe, Asia-Pacific, and the rest of the world. North America contributes to the largest market share due to the rapid growth in the ageing population and the high prevalence of valvular heart diseases. Furthermore, the favourable reimbursement scenario and rising product approvals for the heart valve are also contributing to the growth of the North American prosthetic heart valve market.

The Asia Pacific is also expected to witness the high growth in the next few years, due to the growing incidences of chronic diseases and increasing disposable income.

 Prosthetic heart valve market Growth by Region

Competitive Landscape

A majority of the leading players in this market are focusing on marketing and promotional activities, product launches and approvals, acquisitions, agreements, collaborations, and expansions to enhance their market presence and strengthen their distribution networks, cater to the needs of a growing customer base, widen their product portfolios, and boost their production capabilities.

 

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Prevalence of Heart Valve Disease

      2. 4.2.2 Rising Regulatory Approvals for New and Advanced Prosthetic Heart Valve

    3. 4.3 Market Restraints

      1. 4.3.1 High Cost of Transcatheter Aortic Valve Replacement (TAVR) Procedures

      2. 4.3.2 Availability of Alternative Methods for Treating Heart Valve Diseases (HVD)

    4. 4.4 Porter's Five Forces Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Type of Valve

      1. 5.1.1 Mechanical Heart Valve

      2. 5.1.2 Bioprosthetic Heart Valve

      3. 5.1.3 Transcatheter Heart Valve

    2. 5.2 By Position

      1. 5.2.1 Mitral Valve

      2. 5.2.2 Aortic Valve

      3. 5.2.3 Other Positions

    3. 5.3 Geography

      1. 5.3.1 North America

        1. 5.3.1.1 United States

        2. 5.3.1.2 Canada

        3. 5.3.1.3 Mexico

      2. 5.3.2 Europe

        1. 5.3.2.1 Germany

        2. 5.3.2.2 United Kingdom

        3. 5.3.2.3 France

        4. 5.3.2.4 Italy

        5. 5.3.2.5 Spain

        6. 5.3.2.6 Rest of Europe

      3. 5.3.3 Asia-Pacific

        1. 5.3.3.1 China

        2. 5.3.3.2 Japan

        3. 5.3.3.3 India

        4. 5.3.3.4 Australia

        5. 5.3.3.5 South Korea

        6. 5.3.3.6 Rest of Asia-Pacific

      4. 5.3.4 Middle East & Africa

        1. 5.3.4.1 GCC

        2. 5.3.4.2 South Africa

        3. 5.3.4.3 Rest of Middle East & Africa

      5. 5.3.5 South America

        1. 5.3.5.1 Brazil

        2. 5.3.5.2 Argentina

        3. 5.3.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Medtronic PLC

      2. 6.1.2 Edwards Lifesciences Corporation

      3. 6.1.3 Boston Scientific Corporation

      4. 6.1.4 Livanova PLC

      5. 6.1.5 St. Jude Medical Inc. (An Abbott Laboratories Company)

      6. 6.1.6 Symetis SA

      7. 6.1.7 Jenavalve Technology Inc.

      8. 6.1.8 Cryolife Inc.

      9. 6.1.9 TTK Healthcare Limited

      10. 6.1.10 Colibri Heart Valve LLC

      11. 6.1.11 Lepu Medical Technology Co. Ltd

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Prosthetic Heart Valve Market market is studied from 2018 - 2026.

The Prosthetic Heart Valve Market is growing at a CAGR of 10.5% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Medtronic PLC, Edwards Lifesciences Corporation, Boston Scientific Corporation, Livanova PLC, St. Jude Medical, Inc. (An Abbott Laboratories Company) are the major companies operating in Prosthetic Heart Valve Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!